![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | SLC25A43 | Human | 2,3',4,4',5-Pentachlorobiphenyl | increases expression | ISO | Slc25a43 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:31388691 | SLC25A43 | Human | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Slc25a43 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SLC25A43 mRNA | CTD | PMID:32109520 | SLC25A43 | Human | 2,3,7,8-Tetrachlorodibenzofuran | increases expression | ISO | Slc25a43 (Rattus norvegicus) | 6480464 | 2 more ... | CTD | PMID:32109520 | SLC25A43 | Human | aflatoxin B1 | decreases expression | EXP | | 6480464 | Aflatoxin B1 results in decreased expression of SLC25A43 mRNA | CTD | PMID:21632981 | SLC25A43 | Human | aflatoxin B1 | increases methylation | EXP | | 6480464 | Aflatoxin B1 results in increased methylation of SLC25A43 intron | CTD | PMID:30157460 | SLC25A43 | Human | Aflatoxin B2 alpha | increases methylation | EXP | | 6480464 | aflatoxin B2 results in increased methylation of SLC25A43 intron | CTD | PMID:30157460 | SLC25A43 | Human | all-trans-retinoic acid | decreases expression | EXP | | 6480464 | Tretinoin results in decreased expression of SLC25A43 mRNA | CTD | PMID:21934132 and PMID:33167477 | SLC25A43 | Human | alpha-Zearalanol | multiple interactions | ISO | Slc25a43 (Rattus norvegicus) | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of SLC25A43 mRNA | CTD | PMID:35163327 | SLC25A43 | Human | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of SLC25A43 mRNA | CTD | PMID:21632981 | SLC25A43 | Human | benzo[a]pyrene | decreases methylation | EXP | | 6480464 | Benzo(a)pyrene results in decreased methylation of SLC25A43 3' UTR | CTD | PMID:27901495 | SLC25A43 | Human | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of SLC25A43 intron and Benzo(a)pyrene affects the methylation of SLC25A43 promoter | CTD | PMID:27901495 and PMID:30157460 | SLC25A43 | Human | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of SLC25A43 gene | CTD | PMID:31601247 | SLC25A43 | Human | copper(II) sulfate | decreases expression | EXP | | 6480464 | Copper Sulfate results in decreased expression of SLC25A43 mRNA | CTD | PMID:19549813 | SLC25A43 | Human | Dibutyl phosphate | affects expression | EXP | | 6480464 | di-n-butylphosphoric acid affects the expression of SLC25A43 mRNA | CTD | PMID:37042841 | SLC25A43 | Human | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC25A43 mRNA | CTD | PMID:27188386 | SLC25A43 | Human | doxorubicin | decreases expression | EXP | | 6480464 | Doxorubicin results in decreased expression of SLC25A43 mRNA | CTD | PMID:29803840 | SLC25A43 | Human | ethyl methanesulfonate | decreases expression | EXP | | 6480464 | Ethyl Methanesulfonate results in decreased expression of SLC25A43 mRNA | CTD | PMID:23649840 | SLC25A43 | Human | formaldehyde | decreases expression | EXP | | 6480464 | Formaldehyde results in decreased expression of SLC25A43 mRNA | CTD | PMID:23649840 | SLC25A43 | Human | fulvestrant | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with Fulvestrant] results in increased methylation of SLC25A43 gene | CTD | PMID:31601247 | SLC25A43 | Human | GW 4064 | increases expression | ISO | Slc25a43 (Mus musculus) | 6480464 | GW 4064 results in increased expression of SLC25A43 mRNA | CTD | PMID:26655953 | SLC25A43 | Human | methyl methanesulfonate | decreases expression | EXP | | 6480464 | Methyl Methanesulfonate results in decreased expression of SLC25A43 mRNA | CTD | PMID:23649840 | SLC25A43 | Human | p-chloromercuribenzoic acid | decreases expression | EXP | | 6480464 | p-Chloromercuribenzoic Acid results in decreased expression of SLC25A43 mRNA | CTD | PMID:26272509 | SLC25A43 | Human | p-chloromercuribenzoic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC25A43 mRNA | CTD | PMID:27188386 | SLC25A43 | Human | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of SLC25A43 mRNA | CTD | PMID:25704631 | SLC25A43 | Human | perfluorohexanesulfonic acid | decreases expression | ISO | Slc25a43 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in decreased expression of SLC25A43 mRNA | CTD | PMID:37995155 | SLC25A43 | Human | perfluorooctanoic acid | multiple interactions | ISO | Slc25a43 (Rattus norvegicus) | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in decreased expression of SLC25A43 mRNA | CTD | PMID:35163327 | SLC25A43 | Human | quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of SLC25A43 mRNA | CTD | PMID:21632981 | SLC25A43 | Human | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC25A43 mRNA | CTD | PMID:27188386 | SLC25A43 | Human | sodium dodecyl sulfate | decreases expression | EXP | | 6480464 | Sodium Dodecyl Sulfate results in decreased expression of SLC25A43 mRNA | CTD | PMID:31734321 | SLC25A43 | Human | sunitinib | decreases expression | EXP | | 6480464 | Sunitinib results in decreased expression of SLC25A43 mRNA | CTD | PMID:31533062 | SLC25A43 | Human | thioacetamide | increases expression | ISO | Slc25a43 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of SLC25A43 mRNA | CTD | PMID:23411599 | SLC25A43 | Human | titanium dioxide | decreases methylation | ISO | Slc25a43 (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of SLC25A43 gene | CTD | PMID:35295148 | SLC25A43 | Human | trichostatin A | increases expression | EXP | | 6480464 | trichostatin A results in increased expression of SLC25A43 mRNA | CTD | PMID:24935251 | SLC25A43 | Human | triphenyl phosphate | affects expression | EXP | | 6480464 | triphenyl phosphate affects the expression of SLC25A43 mRNA | CTD | PMID:37042841 | SLC25A43 | Human | urethane | decreases expression | EXP | | 6480464 | Urethane results in decreased expression of SLC25A43 mRNA | CTD | PMID:28818685 | SLC25A43 | Human | valproic acid | increases expression | EXP | | 6480464 | Valproic Acid results in increased expression of SLC25A43 mRNA | CTD | PMID:24935251 and PMID:29154799 | |